Friday, June 20, 2025
8:00 AM-9:00 AM ET
Foxboro, MA
Neurology Center of New England, PC
9 Payson Road
Foxborough, MA 02035
Abington Neurological Associates
Abington, Pennsylvania
Target Audience
The educational design of this activity addresses the needs of neurology, radiology, emergency, geriatric, and primary care clinicians, and infusion center staff (physicians, nurse practitioners, physician assistants, nurses, and administrative staff) who are involved in the management of patients with AD.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify patients eligible for treatment with antiamyloid mAbs
- Review strategies to identify and address adverse events associated with antiamyloid mAbs
- Describe necessary components of clinic protocols for administering antiamyloid mAbs
- Establish interdepartmental communication regarding administration of antiamyloid mAbs, routine monitoring, and management of adverse events
Physician Accreditation Statement
Integritas Communications is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
Integritas designates these live activities for a maximum of 1.0 AMA PRA Category 1 Credit™ each, for a total of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Nurses Credentialing Center’s (ANCC) Commission on Accreditation recognizes educational activities that are approved for AMA PRA Category 1 Credits™ by providers who are accredited by the ACCME to award credit to learners. This reciprocity agreement allows nurses and nurse practitioners to use AMA PRA Category 1 Credits™ as approved ANCC contact hours for license renewal.
Integritas Contact Information
For more information about the approval of this program, please contact Integritas at info@exchangecme.com.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must attend the live meeting and complete the posttest and program evaluation.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Conflicts of Interest
Integritas adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the ACCME and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Integritas are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integritas does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact us prior to the live event at info@exchangecme.com.
Register Now


18
2025
Neurology Center of New England, PC
Workshop 2
Time: | 8:00 AM-9:00 AM ET |
Venue: | Neurology Center of New England, PC |
Location: | Foxboro, MA |
Faculty: | David C. Weisman, MD |